Johnson Investment Counsel’s Integra LifeSciences IART Stock Holding History

Johnson Investment Counsel’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-13,394	Closed	-$914K	–	656
2021 Q2	$914K	Sell	13,394 -13,820	-51%	-$977K	0.01%	347
2021 Q1	$1.88M	Buy	27,214 +220	+0.8%	+$14.9K	0.03%	224
2020 Q4	$1.75M	Buy	26,994 +6	+0%	+$323	0.03%	214
2020 Q3	$1.27M	Buy	26,988 +4,491	+20%	+$214K	0.02%	244
2020 Q2	$1.06M	Hold	22,497	–	–	0.02%	272
2020 Q1	$1M	Hold	22,497	–	–	0.02%	250
2019 Q4	$1.31M	Buy	22,497 +3,879	+21%	+$231K	0.02%	263
2019 Q3	$1.12M	Hold	18,618	–	–	0.02%	274
2019 Q2	$1.04M	Buy	+18,618	New	+$959K	0.02%	301

Other funds holding IART

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Johnson Investment Counsel's IART Position: Q3 2021 in Review

Johnson Investment Counsel sold out of Integra LifeSciences (IART) in Q3 2021, closing a stake of 13,394 shares — an estimated $914K sold.

Johnson Investment Counsel first reported a position in IART in Q2 2019 and held it in 9 quarters. The position peaked at $1.88M in Q1 2021. 261 funds tracked by Wall St. Rank hold IART as of Q3 2021.

Johnson Investment Counsel reported no remaining Integra LifeSciences position as of Q3 2021 after selling out during the quarter.
Johnson Investment Counsel sold 13,394 Integra LifeSciences shares in Q3 2021, an estimated $914K.
Johnson Investment Counsel first reported a position in Integra LifeSciences in Q2 2019 and held it in 9 quarters.
Johnson Investment Counsel's Integra LifeSciences position peaked at $1.88M in Q1 2021.
261 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2021.

Based on Johnson Investment Counsel's 13F filing for Q3 2021, filed 12 Nov 2021.